Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 147359-76-0
2. Flibanserin Hcl
3. Flibaserin
4. Flibanserin Hydrochloride [mi]
5. Flibanserin (hydrochloride)
6. 96xtc36k1b
7. 3-[2-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]ethyl]-1h-benzimidazol-2-one;hydrochloride
8. 1-(2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1h-benzo[d]imidazol-2(3h)-one Hydrochloride
9. 2h-benzimidazol-2-one, 1,3-dihydro-1-(2-(4-(3-(trifluoromethyl)phenyl)-1-piperazinyl)ethyl)-, Hydrochloride
10. 1-(2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1,3-dihydro-2h-benzo[d]imidazol-2-one Hydrochloride
11. Unii-96xtc36k1b
12. Flibanserinhydrochloride
13. Bimt 17 Hydrochloride
14. Bimt 17bs Hydrochloride
15. Schembl563586
16. Hy-a0095a
17. Amy16553
18. Bcp15754
19. Ex-a2808
20. Xfa35976
21. Mfcd29058559
22. Akos026674090
23. Ds-9963
24. 2h-benzimidazol-2-one, 1,3-dihydro-1-[2-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]ethyl]-, Hydrochloride (1:1)
25. Ac-31715
26. Cs-0027380
27. A925155
28. Q27271942
Molecular Weight | 426.9 g/mol |
---|---|
Molecular Formula | C20H22ClF3N4O |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 4 |
Exact Mass | 426.1434235 g/mol |
Monoisotopic Mass | 426.1434235 g/mol |
Topological Polar Surface Area | 38.8 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 550 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?